Mylan Nv Ord Shs (NASDAQ: MYL)
| Last Price | $39.03 |
| Net Change | $0.02 (0.05%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $39.03 |
| Previous Close Price | $39.01 |
| High Price | $39.29 |
| Low Price | $38.67 |
| Number of Trades | 27,382 |
| Volume | 16,048,900 |
| Fifty Two Week High | $50.4 (2016-08-09) |
| Fifty Two Week Low | $33.6 (2016-11-03) |
| Average Daily Volume | 5,745,539 |
| Share Outstanding | 535,980 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $0.93 (2017-05-10) |
| 2nd Quarter Earnings | $1.38 (2016-11-09) |
| 3nd Quarter Earnings | $1.16 (2016-08-09) |
| 4th Quarter Earnings | $0.76 (2016-05-03) |
| PE Ratio | $7.74 |
| EPS Growth | $7.33 |
| Recent Earnings | $0.93 |
| Annual EPS | $5.04 |
| Last Quarter EPS | $ |
| Market Capitalization | $20.92B |
| Insider Shareholders % | 0.0069% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 535,980 |
| Inst. Shareholder % | 69.89% |
| Annual Net Income | $0.53B |
| TTM Net Profit Margin | $4.59 |
| 1-Year Return | -10.4% |
| 3-Year Return | -24.4% |
| 5-Year Return | 87.64% |
| 5-Year Revenue Growth | 80.7% |
| 5-Year Earnings Growth | 149.49% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | 7.33% |
| Dividends per Share | $0.06 |
| Stock Split Ratio | 3-2 |
| Beta | 1.23 |
MYL News & Stock Updates
June 1, 2017
How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top ExecsMay 2, 2017
The Hidden Player That's Jacking Up Drug Prices (Hint: It's Not Big Pharma)December 15, 2016
The Five Most Outrageous Drug Price Increases of 2016October 28, 2016
5 Drug Price Increases That Will Have You Seeing RedOctober 10, 2016
Dow Jones Industrial Average Today Pushes Higher with Oil Prices in Focus